Tata India Pharma and Healthcare Fund · Regular · Growth
NAV
₹31.4008
as of 16 Jun 2026
Expense Ratio
2.11%
AUM
₹1,278 Cr
Lumpsum returns (CAGR)
- 1Y
- +4.45%
- 3Y
- +20.99%
- 5Y
- +13.42%
- Since Inception
- +11.55%
SIP returns (XIRR)
- 1Y
- +8.62%
- 3Y
- +12.19%
- 5Y
- +15.22%
- Since Inception
- +15.81%
Beat the benchmark — ₹100/month SIP
Same SIP in this fund vs the benchmark index
This fund
₹29,978
Benchmark
₹26,401
+₹3,577 extra wealth vs the benchmark index
Backtest this SIP yourselfSIP since inception — what ₹100/month became
Real NAV backtest from day one
₹12,600
Invested
₹29,978
Value today
15.8%
XIRR (p.a.)
₹100/month SIP from fund inception · Current value as of today
Try SIP Calculator with this fund's history₹5,000 lumpsum at launch — value today
Invested on the fund's first NAV date
₹5,000
Invested
₹15,612
Value today
11.5%
CAGR (p.a.)
One-time investment at fund inception · Growth purely from NAV appreciation
Try Lumpsum Calculator₹10L corpus with ₹5,000/month withdrawals since inception
Corpus is still growing despite monthly payouts
₹10,00,000
Initial corpus
₹6,30,000
Withdrawn
₹16,23,535
Corpus left
+₹12,53,535 net gain — withdrew ₹6,30,000 AND corpus grew
Plan your SWP with real NAV₹6L corpus via 12-month STP from a liquid fund at inception
₹50K/month transferred from HDFC Liquid → this fund at launch
₹6,00,000
Invested
₹19,94,733
Value today
+6.5%
vs lumpsum
STP beat direct lumpsum by 6.5% — reduced timing risk paid off
Model your own STP with real NAV₹1 lakh on the worst crash day — 22 Mar 2020
Worst single-day Nifty drop during this fund's life
₹1,00,000
Invested
₹3,77,451
Value today
3.8×
Multiple
Staying invested through that crash turned ₹1L into ₹3,77,451 — a 3.8× return
Read: Staying invested through crashesRisk Metrics
Trailing 1 year, annualised-0.28
Sharpe Ratio
-0.03
Alpha
0.36
Beta
-0.26
Sortino
14.10%
Std Dev
-16.99%
Max Drawdown
Performance Comparison
Thinking about Tata India Pharma and Healthcare Fund · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Portfolio holdings
- 1Sun Pharmaceutical Industries Ltd9.87%
- 2Divi Laboratories Ltd5.92%
- 3Healthcare Global Enterprises Ltd5.45%
- 4Abbott India Ltd5.37%
- 5Max Healthcare Institute Ltd5.17%
- 6Cipla Ltd5.07%
- 7Rainbow Childrens Medicare Ltd4.23%
- 8Apollo Hospitals Enterprise Ltd4.06%
- 9Mankind Pharma Ltd3.73%
- 10Dr Reddys Laboratories Ltd3.73%
Investment Objective
Tata India Pharma and Healthcare Fund · Regular · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
Tata India Pharma and Healthcare Fund · Regular · Growth is a Sectoral / Thematic mutual fund offered by Tata Mutual Fund. The fund has been operational for over 10 years. It manages assets worth ₹1,278 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against BSE Healthcare. The current expense ratio is 2.11%.
Who Should Invest?
- •Aggressive investors comfortable with significant short-term volatility
- •Investors with a long-term horizon of 7+ years who can ride out market cycles
- •SIP investors who can benefit from rupee cost averaging during market fluctuations